BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,004 filers reported holding BAXTER INTL INC in Q3 2022. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,518,417 | -21.3% | 75,289 | +0.6% | 0.03% | -23.5% |
Q1 2024 | $3,198,362 | +19.2% | 74,833 | +7.8% | 0.03% | +6.2% |
Q4 2023 | $2,684,202 | +4.1% | 69,431 | +1.6% | 0.03% | -8.6% |
Q3 2023 | $2,579,718 | -17.1% | 68,355 | +0.1% | 0.04% | -14.6% |
Q2 2023 | $3,110,837 | +5.2% | 68,280 | -6.3% | 0.04% | -4.7% |
Q1 2023 | $2,956,337 | -16.0% | 72,888 | +5.6% | 0.04% | -24.6% |
Q4 2022 | $3,518,918 | +11.7% | 69,039 | +18.0% | 0.06% | -6.6% |
Q3 2022 | $3,150,000 | -0.7% | 58,486 | +18.4% | 0.06% | -4.7% |
Q2 2022 | $3,172,000 | -49.5% | 49,386 | -39.0% | 0.06% | -38.5% |
Q1 2022 | $6,283,000 | +132.3% | 81,023 | +157.1% | 0.10% | +147.6% |
Q4 2021 | $2,705,000 | +32.6% | 31,515 | +24.2% | 0.04% | +7.7% |
Q3 2021 | $2,040,000 | -8.7% | 25,368 | -8.6% | 0.04% | -4.9% |
Q2 2021 | $2,234,000 | -39.6% | 27,753 | -36.7% | 0.04% | -47.4% |
Q1 2021 | $3,698,000 | +4.0% | 43,848 | -1.1% | 0.08% | +1.3% |
Q4 2020 | $3,557,000 | +3.4% | 44,327 | +3.7% | 0.08% | -9.4% |
Q3 2020 | $3,439,000 | -6.7% | 42,764 | -0.1% | 0.08% | -10.5% |
Q2 2020 | $3,686,000 | – | 42,813 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |